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A B S T R A C T: 
Multiple sclerosis (MS) is an autoimmune disease in which immune cells attacks the body cells mistakenly; it is 
characterized by chronic inflammation that leads to demyelination and conduction of nerve impulse is affected negatively. The 
cause of the disease is unknown, but it may be partially under the control of genetics, including interleukin 7 receptor alpha 
(IL7Rα). In this case-control study, 40 relapsing-remitting MS (RRMS) male patients, which fulfills McDonald criteria and 40 
healthy controls, with matched sex, were compared depending on the rs6897932 polymorphism within the exon 6 of IL7Rα gene 
by Tetra-amplification refractory mutation system polymerase chain reaction (Tetra-ARMS-PCR) method. The frequency of T 
allele of IL7Rα rs6897932 was considerably higher in male MS patients than healthy control males (31.25 vs 17.5%). Genotype 
distributions of the single nucleotide polymorphism (SNP) rs6897932 deviated from Hardy-Weinberg equilibrium with a p-value 
of 0.80. Both homozygous (TT) and Heterozygous (CT) were non-significantly positively associated with MS male patients (OR 
= 6.75, 95%CI = 0.73-62.4, p = 0.059, OR = 1.68, 95%CI = 0.64-4.38, p = 0.28) respectively. The distribution of the rs6897932 
polymorphism is not significantly different in our case/control study in the Erbil province. 
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1. INTRODUCTION  
 
Multiple sclerosis (MS) is a long-standing 
autoimmune disease that occurs by the 
inflammation in the central nervous system (CNS) 
and results in demyelination and impairment of 
axons (Valcarcel et al., 2018, Gold et al., 2012). It 
can be classified as an autoimmune disease that 
impacts CNS and distinguished by numerous 
brain and spinal cord lesions (Rosati, 2001, 






The disease is expected to influence 
approximately two and a half million people in the 
world (Rosati, 2001). Furthermore, MS is more 
common in females than in males. Currently, the 
rate of females with this disease to males is 2–1 
(Ascherio and Munger, 2016). 
MS etiology is unclear, but several studies have 
already shown that causative agents of MS is 
reliant on a strong genetic factor (Akkad et al., 
2009). Several different methods have been used 
to determine the genetic bases of MS, such as 
genetic linkage, gene expression and candidate 
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gene association (Gregory et al., 2007, Rizvi et 
al., 2020). 
Amongst the association study is a viable 
approach toward recognizing the risk genetic loci 
of genes as a marker such as SNP. Among these 
was reported the relationship of many IL-7 
receptor SNPs with MS in various ethnic groups 
(Sahami-Fard et al., 2020, Zhang et al., 2019). 
The position of IL7R is chromosome 5 short arm 
13 (5p13). This gene consists of γ chain (IL7Rγ) 
and α chain (IL7Rα) usually recognized as CD132 
and CD127 respectively. The SNPs throughout the 
alpha chain of IL7R gene have a big role in the 
impairment of immune system homeostasis and 
this prone to MS easily (Zhang et al., 2005, 
Čierny et al., 2015).  
Appropriately, association studies for the variants 
of IL7Rα gene revealed that rs6897932 in the exon 
6 might be a causative factor for MS evolving in 
many Japanese and European communities 
(Gregory et al., 2007, Weber et al., 2008, Fang et 
al., 2011). 
In the exon number 6 of IL7Rα gene there is SNP 
called rs6897932 induces non-conservative amino 
acid transition at location 244 in which isoleucine 
shifted to threonine 244 (Ile → Thr) (ATC / ACC) 
(Teutsch et al., 2003). This amino acid shift 
affects the expression product of IL7Rα which 
results in the variation amount of membrane-
bound isoform and soluble form. Such 
modifications are accompanied by the regulation 
of the IL7 signaling pathway and a direct 
association MS with this SNP (Gregory et al., 
2007).  
Before many types of researches have been done, 
most of them have assessed the relationship of 
T244I variant, rs6897932 with MS pathology, 
while other researches couldn’t find any 
connection between them. Studies that recently 
done have shown that the C allele is slightly more 
prevalent than the T allele. Also, it has been 
suggested in region rs6897932 the C allele will 
lead to a higher threat of MS in some population 
(Gregory et al., 2007, Weber et al., 2008, Fang et 
al., 2011). Therefore, the opportunity to have MS 
will increase by 1.5 and 1.3 folds for the 
genotypes CC and CT respectively, if we 
deliberated that genotype TT as a normal risk. 
Dependent on many types of researches with 
varied results about the polymorphism rs6897932, 
it is difficult to know for sure concerning the 
interaction of this SNP with MS (Čierny et al., 
2015). 
To arrive at a definite conclusion, we decided to 
have this study in Erbil province-Iraq to evaluate 
the importance of the IL7Rα gene polymorphisms, 
rs6897932 in such community and investigate 
their influence on IL7Rα gene expression 
concerning MS pathogenesis. 
2. MATERIALS AND METHODS  
2.1. Sample Collection 
Forty males with MS patients enrolled in this 
study who visited department of neurology, 
Rzgari hospital in Erbil city-Iraq from April to 
June of 2015, and they were diagnosed according 
to 2005 revised McDonald criteria. Forty control 
males who were age-matched with MS patients.  
2.2.  Molecular Technique Analysis 
2.2.1. Genomic DNA Extraction from Human 
Blood Samples 
Human Blood samples were taken from peripheral 
veins using the five-milliliter syringe. The blood 
put into K2EDTA (5.4mg) tube for direct DNA 
extraction. The Genomic DNA extracted from 
whole blood samples by using spin column 
method (AccPrep Genomic DNA extraction Kit- 
Bioneer, South Korea), depending on the 
manufacturer’s instructions. Then the 
concentration and purity of genomic DNA 
extracted from each human blood samples were 
determined using Nano-Drop ™ (Thermo 
Scientific, USA) spectrophotometer by recording 
the concentration ranged (11.05-61.60 ng/µl) and 
purity (1.69-2.27) for each sample.  
2.2.2. Genotyping IL7Rα Gene Polymorphism 
(PCR Amplification) 
Genotyping of the SNP rs6897932 C>T that 
located in exon 6 of IL7Rα gene performed by a 
rapid and cost-effective technique called the 
Tetra-ARMS-PCR method in Tishk International 
University. In this polymorphism one sequence-
specific forward primers: 5′-
AAGAAGGGAAGAGAGCATTGG-3′, and three 
sequence-specific reverse primers that two of 
them: 5′-GAAAAAACTCAAAATGCTGATGG-
3′ (for C allele) and 5′-AGAAAAAACT 
CAAAATGCTGATGA-3′ (for T allele) and one 
reverse were a primer for internal control 5′ 
TTACTTTGGGGACAGCGTTT-3′ used 
(Majdinasab et al., 2014). 
The total of 25 µl volume of PCR master mix 
reaction achieved containing 3µl of genomic 
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DNA, 12.5 µl of Taq DNA Polymerase 2x Master 
Mix RED (Ampliqon, Danish) and 1µl was added 
for each of the forward and reverse primers for 
IL7Rα gene. Then the mixture was completed by 
adding 3.5 µl of nuclease-free water (Čierny et al., 
2015). 
The program of PCR amplification consisted of an 
initial denaturation at 94 °C for 5 minutes 
followed by the next 35 cycles 94 °C for 30 
seconds (denaturation), 62 °C for 30 seconds 
(annealing),72 °C for 30 seconds (elongation) and 
the final step at 72 °C for 5 minutes to extend all 
PCR fragments (Majdinasab et al., 2014). After 
PCR amplification, the PCR DNA amplicons 
separated on 1.5% agarose gel (after applying 5 
V/cm) (Magdeldin, 2012), then the separated 
bands were stained with ethidium bromide to 
visualize under UV light (Bio-Rad UV-
transilluminator) (Brown, 2016). The 301 bp mean 
the appearance of IL-7R gene polymorphism in 




Figure 1. Gel electrophoresis for the IL7Rα 
rs6897932 gene showing the T and C alleles in 
some MS patients. Band 301bp indicates the 
presenece of T or C alleles. Sample 1 (lane 1C and 
1T) has TT genotypes, sample 2 (lane 2C and 2T) 
has CT genotype and sample 3 (lane 3C and 3T) 
has CC genotype, M= 250 bp DNA ladder. 
 
2.3. Statistical Analysis 
GraphPad Prism 6 statistical software used for 
statistical analysis. A student t-test used to 
compare the ages between MS patients and 
healthy controls. Genotype and allele frequencies 
of MS patients and healthy controls were analyzed 
using the Chi-square (χ2) test. Both genotype and 
allelic odds ratio (ORs) and 95% confidence 
interval (CI) calculated to determine the 
association of the SNP in exon 6 of the IL7Rα 
receptor gene polymorphisms with MS. A p-value 
of less than 5% ( p <0.05) set to be statistically 
significant. 
3. RESULTS 
Demographic profiles of both male MS 
patients and healthy control males had shown in 
table 1. The mean age of MS patients was 34.85 ± 
1.442 years, and of the control group was 32.25 ± 
1.375 years; yielding no statistically significant 
difference in their ages. In this case-control study, 
40 MS patients and 40 healthy controls compared 
depending on the rs6897932 polymorphism within 
the exon 6 of IL7Rα gene by Tetra-ARMS-PCR 
method. The genotype and allele frequencies of 
IL7Rα rs6897932 are given in (Table 2). The 
frequency of the T allele of IL7Rα rs6897932 was 
not significantly changed in male MS patients 
than healthy control males (31.25 vs 17.5%). 
Genotype distributions of the SNP rs6897932 
deviated from Hardy-Weinberg equilibrium with a 
p-value of 0.80. The significance association was 
not found in both homozygous (TT) and 
Heterozygous (CT) in MS male patients (OR = 
6.75, 95%CI = 0.73-62.4, p = 0.059, OR = 1.68, 
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Table 1. Age of MS patients and controls 
Variable Age Range (years) Mean Age ± SE 
MS Patients 20-50 34.85 ± 1.442 
Controls 20-50 32.25 ± 1.375 
 
Table 2. Association of MS with carriage of alleles/genotypes of IL7Rα rs6897932 SNP 
Polymorphism MS (n=40) Control (n=40) OR 95% CI p-value HWE 
No. % No % 
CC 20 50.0 27 67.5 1.0 - - 0.80 
CT 15 37.5 12 30.0 1.688 0.64-
4.38 
0.28 
TT 5 12.5 1 2.5 6.75 0.73-
62.4 
0.059 
C-Allele 55 68.75 66 82.5 2.143 1.016-
4.518 
0.0428  
T-Allele 25 31.25 14 17.5 
 
4. DISCUSSION 
Multiple sclerosis (MS) is an autoimmune disease, 
which is characterized by demyelination of the 
axon of neurons in the CNS and predominant of 
inflammation. The etiology of the disease is not 
well known, but it may be under genetics and 
environmental factors (Dyment et al., 1997). The 
genes, which are involved and increased 
susceptibility to the disease, are divided into two 
groups: HLA genes (Sawcer et al., 2011) and non-
HLA genes (Rounachi et al., 2009). The most 
HLA gene which is related to MS is HLA- DRB1* 
1501 class II allele (Alcina et al., 2010), it is 
located on chromosome 6p21. Besides HLA genes 
there are many genes which are proposed by 
GWAS that candidates be involved in the 
development and severity of the MS. Non-HLA 
genes have a role in regulation and modulation of 
cytokine, cytokine receptor, transcription factor 
and T lymphocyte receptor (Rounachi et al., 
2009). Non-HLA genes that are usually involved 
in MS are CD 25, EVI5, CD58, CD154 and 
IL7Rα.  
Interleukin 7 receptor alpha (IL7Rα, also known 
as CD127), is one of the most critical genes which 
has a role in developing MS. It located on 
chromosome 5p13.2. It expressed on B and T 
lymphocytes, it has essential in maturation, 
developing and survival of them (Manolio et al., 
2009). There are many SNP of IL7Rα but, the 
most critical SNP in MS is (rs6897932, p.T244I) 
which is vital for developing IL7Rα in the form of 
membrane-bound or the way of the soluble 
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receptor, in this manner it is involved in 
developing MS (Booth et al., 2005, Zuvich et al., 
2009). Since, rs6897932 polymorphism of IL7Rα 
controlling post-transcription modification and 
alternative splicing the exon 6 of pre-mature 
mRNA of IL7Rα (Booth et al., 2005). The allele 
of “C” has a role in skipping alternative splicing 
the exon 6, and developing a soluble form of 
IL7Rα while, The allele of “T” has a role 
alternative splicing the exon 6 and developing a 
membrane-bound type of IL7Rα (Gregory et al., 
2007). The carriers of the "T" allele believed to be 
a predisposing factor for developing MS because 
it leads to the formation of the more membrane-
bound form of IL7Rα and the creation of more 
auto-reactive T and B lymphocyte (Gregory et al., 
2007). 
Another explanation for the role of IL7Rα in 
the pathogenesis of RRMS is that IL7Rα down-
regulates the forkhead box P3 (FoxP3) which is, 
in turn, is the transcription factor for developing 
CD4+CD25+ regulatory T (T reg) cells, T reg 
cells is crucial in promoting tolerance and 
suppress autoreactive T lymphocyte. IL7Rα by 
decreasing FoxP3 can breakdown tolerance and 
developing an autoimmune disease, e.g. MS . The 
results of the current analysis are inconsistent with 
O'Doherty et al. (2008), Alcina et al. (2008) and 
Majdinasab et al. (2014) who found that 
rs6897932 polymorphism of IL7Rα was related 
with MS in UK, Spain and Iran, respectively. 
 
CONCLUSIONS 
In summary, there is no association between 
rs6897932 polymorphism of IL7Rα and RRMS 
patients in the Erbil province, by comparing this 
variant in control and MS groups. This study 
confirmed that rs6897932 polymorphism of IL7Rα 
is not a predisposing factor for developing the 
disease in the Erbil province. 
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